Astrocytoma IDH Mutant Grade 2
6 clinical trials · Condition
◉ Watch Astrocytoma IDH Mutant Grade 2
| Record | Firm | Date |
|---|---|---|
| Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma (NCT03528642) | National Cancer Institute (NCI) | 2019-05-01 |
| GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) (NCT07673666) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
Track Astrocytoma IDH Mutant Grade 2 automatically
Every clearance here is in the API, with alerts when new ones post.